Advanced Health Limited (JSE:AVL) News - Trading Statement ADVANCED HEALTH LIMITED (Incorporated in the Republic of South Africa) (Registration number 2013/059246/06) (“the Company” or “Advanced Health”) ISIN Code: ZAE000189049 JSE Code: AVL TRADING STATEMENT In terms of paragraph 3.4(b)(i) of the Listings Requirements of the JSE Limited, listed companies are required to publish a trading statement as soon as they become reasonably certain that the financial results for the next period to be reported on will differ by more than 20% from those of the previous corresponding period. The directors of Advanced Health hereby advise shareholders that, in respect of the reviewed consolidated results for the six months ended 31 December 2021, the Company expects a 3.1% improvement in a loss per of 2.81 cents compared to a loss per share of 2.90 cent in the comparative period. The headline loss per share for the six months ended 31 December 2021 is expected to be 2.81 cents compared to a headline loss per share of 2.16 cent in the comparative period, a 30.1% increase in headline loss per share. The information in this trading statement has not been reviewed and reported on by the Company’s auditors. Pretoria 24 February 2022 Designated Advisor Grindrod Bank Limited Date: 24-02-2022 03:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.